04:07 PM EDT, 06/03/2024 (MT Newswires) -- Elizabeth Crowley, Senior Vice President, Chief Product Development Officer, on May 30, 2024, sold 38,597 shares in Celldex Therapeutics ( CLDX ) for $1,298,384. Following the Form 4 filing with the SEC, Crowley has control over a total of 9,074 shares of the company, with 9,074 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/744218/000141588924015137/xslF345X03/form4-06032024_080604.xml
Price: 34.00, Change: +0.53, Percent Change: +1.58